Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London · Delayed Price · Currency is GBP · Price in USD 795.78
-12.37 (-1.53%)
At close: Jan 9, 2026
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 60.96 billion as of January 9, 2026. Its market cap has decreased by -0.84% in one year.
Market Cap
60.96B
Enterprise Value
49.01B
Revenue
10.60B
Ranking
n/a
PE Ratio
17.90
Stock Price
795.78
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 60.96B, an increase of 63,324.81%. That is a compound annual growth rate of 21.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 60.96B | 3.61% |
| Dec 31, 2025 | 58.84B | -3.88% |
| Dec 31, 2024 | 61.22B | -16.52% |
| Dec 29, 2023 | 73.33B | 14.66% |
| Dec 30, 2022 | 63.95B | 31.15% |
| Dec 31, 2021 | 48.76B | 30.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.86B |
| GSK plc | 75.87B |
| Haleon | 33.12B |
| Smith & Nephew | 10.78B |
| Convatec Group | 4.73B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.72B |